Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 25;52(2):494-504.
doi: 10.3906/sag-2106-324. eCollection 2022.

The effectiveness of anti-interleukin-1 therapy on subclinical inflammation parameters during the attack-free period in familial Mediterranean fever patients: A case-control study

Ebru Atalar  1 , İsmail Doğan  1 , Kevser Gök  1 , Serdar Can Güven  1 , Yüksel Maraş  1 , Gülay Güleç Ceylan  2 , Sükran Erten  1
Affiliations

The effectiveness of anti-interleukin-1 therapy on subclinical inflammation parameters during the attack-free period in familial Mediterranean fever patients: A case-control study

Ebru Atalar et al. Turk J Med Sci. .

Abstract

Background/aim: Anti IL-1 therapy is useful in suppressing attacks in FMF patients with colchicine resistance, however, it is not certain whether subclinical inflammation can sufficiently be inhibited with anti-IL-1 therapy in FMF patients with amyloidosis.

Materials and methods: Forty-six FMF patients receiving anti-interleukin-1 therapy and 36 healthy control patients were compared in terms of laboratory parameters. Also, FMF patients were further divided into two groups; those with amyloidosis and those without it, and these subgroups were compared to each other in terms of clinical and laboratory findings.

Results: In comparison between the FMF and healthy control groups, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level, and red cell distribution width (RDW) level were detected to be higher and hemoglobin level lower in the patient group. Within the FMF patient group, the ESR, CRP, fibrinogen, RDW, and NLR values were significantly higher in the subgroup with amyloidosis in comparison to the subgroup without amyloidosis.

Conclusion: Anti-interleukin-1 therapy could not fully suppress the subclinical inflammatory parameters when compared to healthy individuals.

Keywords: Amyloidosis; anti-IL-1 therapy; antiinflammatory agents; biological therapy; familial Mediterranean fever; inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graph showing the correlation between the CRP and RDW levels in FMF patients.
Figure 2
Figure 2
Graph showing the correlation between the CRP and fibrinogen levels in FMF patients.
Figure 3
Figure 3
ROC curve analysis of RDW, fibrinogen, and NLR as a diagnostic marker for amyloidosis positivity in FMF patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227–253. doi: 10.1016/0002-9343(67)90167-2. - DOI - PubMed
    1. Heller H, Sohar E, Pras M. Ethnic distribution and amyloidosis in familial Mediterranean fever (FMF) Pathol Microbiol (Basel) 1961;24:718–723. doi: 10.1159/000161188. - DOI - PubMed
    1. Kees S, Langevitz P, Zemer D, Padeh S, Pras M, et al. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF) QJM. 1997;90(10):643–647. doi: 10.1093/qjmed/90.10.643. - DOI - PubMed
    1. Guzel S, Andican G, Seven A, Aslan M, Bolayirli M, et al. Acute phase response and oxidative stress status in familial Mediterranean fever (FMF) Mod Rheumatol. 2012;22(3):431–437. doi: 10.1007/s10165-011-0517-5. - DOI - PubMed
    1. Uslu AU, Deveci K, Korkmaz S, Aydin B, Senel S, et al. Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int. 2013;2013:185317. doi: 10.1155/2013/185317. - DOI - PMC - PubMed